Lipocine
LPCN
LPCN
32 hedge funds and large institutions have $2.12M invested in Lipocine in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
76% less capital invested
Capital invested by funds: $8.88M → $2.12M (-$6.76M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $3K
Holders
32
Holding in Top 10
–
Calls
–
Puts
$3K
Top Buyers
| 1 | +$498K | |
| 2 | +$154K | |
| 3 | +$142K | |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$105K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$79.6K |
Top Sellers
| 1 | -$404K | |
| 2 | -$141K | |
| 3 | -$124K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$111K |
| 5 |
FIA
FNY Investment Advisers
New York
|
-$74K |